Bedrijfsoverzicht
Molina Healthcare, Inc. operates within the healthcare sector, specifically serving as a provider of managed healthcare services to low-income families and individuals through the Medicaid, Medicare, and state insurance marketplaces in the United States. The company executes its operations across four distinct segments, which include Medicaid, Medicare, Marketplace, and Other, reflecting a diversified approach to delivering essential coverage. Molina Healthcare, Inc. holds a market capitalization of $7.60B and reported annual revenue of $43.56B over the trailing twelve months, employing a workforce of 19,000 individuals. These valuation and revenue figures indicate a substantial market presence, positioning the firm as a significant player within the healthcare plans industry despite its specialized focus on government-sponsored programs.
Financiële gezondheid
Over the trailing twelve months, the company generated revenue of $43.56B, resulting in a net income of $472.00M and an EBITDA of $902.00M, which highlights a significant gap between top-line revenue and bottom-line earnings that underscores a high cost structure and substantial operational expenses. The free cash flow stands at -$100,000,000, indicating a current cash outflow that limits immediate financial flexibility and suggests that capital expenditures or working capital requirements currently exceed operating cash generation. Gross margins are reported at 9.4%, operating margins are -1.5%, and profit margins are 1.1%, illustrating that the company operates with thin gross profitability and negative operating leverage before reaching a slight positive profit margin. The balance sheet shows a cash position of $8.26B against total debt of $4.05B, supported by a debt-to-equity ratio of 99.44, which reflects a capital structure that is leveraged yet supported by a robust cash reserve. Liquidity is supported by a current ratio of 1.69, signaling that the company possesses sufficient current assets to cover its short-term liabilities without immediate distress. Return on equity is 11.0% and return on assets is 3.1%, metrics that reveal management's ability to generate returns relative to shareholders' equity and the total asset base, respectively.
Waarderingsbeoordeling
The trailing twelve-month P/E ratio is 16.37, while the forward P/E is 16.85, suggesting that the market expects a modest increase in earnings relative to current performance levels. The price-to-book ratio is 1.83, indicating that the stock trades at a premium of approximately 83% over its book value, which may reflect market expectations for future growth or intangible asset value. Alternative valuation metrics include a price-to-sales ratio of 0.17 and an EV/EBITDA of 3.66, figures that suggest the market values the company at a fraction of its sales, potentially due to the capital-intensive nature of the healthcare delivery model. Regarding trading range, the 52-week high is $351.95 and the 52-week low is $121.06, providing a historical context for price volatility without specifying the exact current price position. The beta is 0.55, which indicates that the stock's price volatility is significantly lower than the broader market, suggesting lower systematic risk compared to the overall index.
Growth & Income
Revenue growth year-over-year is 7.1%, while earnings growth is marked as N/A, preventing a direct comparison of earnings trajectory versus revenue expansion in the most recent period. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which implies that the firm retains all earnings for reinvestment into operations, debt reduction, or future growth initiatives rather than distributing income to shareholders. This non-dividend strategy aligns with the company's focus on expanding its managed care footprint and managing the complex regulatory environment of Medicaid and Medicare programs. Consequently, the overall growth and income profile is characterized by capital appreciation potential driven by organic revenue expansion rather than income generation through dividend distributions.